“…In the short term, we observed the persistence and even the progression of SOS and NRH in the setting of two‐stage hepatectomies, 10 suggesting that there is no advantage in delaying an operation that is otherwise well timed in terms of tumour response to chemotherapy. In the long term, the issue is more open: analogy with the settings of toxic oil syndrome, in which NRH and portal hypertension were noted 2.5 years after consuming the oil 44 azathioprine and 6‐thioguanine, suggests that the changes are not reversible; and we observed persistent SOS, NRH and even fibrosis several months after chemotherapy had been interrupted in some patients undergoing repeat hepatectomies for recurrence 11 . However, we have recently operated on patients in whom severe OX‐related changes present at the first operation had reverted to normal at the second hepatectomy.…”